| Dec-2021 | SAFETY AND IMMUNOGENICITY OF SARS-COV-2 VACCINES IN PATIENTS WITH CHRONIC LIVER DISEASES (CHESS-NMCID 2101): A MULTICENTER STUDY | Wang, Jitao; Ai, Jingwen; Liu, Dengxiang; Xiang, Huiling; Guo, Ying; Lv, Jiaojian; Zhang, Qiran; Li, Jinlong; Zhang, Xiaochong; Li, Qianqian; Jing, Liang; Guo, Xiaoqing; Feng, Yinong; Lan, Xiaoling; Zhang, Xuying; Qin, Wei; Wang, Xiaodong; Rao, Wei; Zhang, Qun; Tian, Qiuju; Zhang, Yanliang; Xie, Faren; Jiang, Shujun; Yan, Yan; Qiu, Yuanwang; Wu, Hangyuan; Hou, Zhiyun; Zhang, Nina; Zhang, Aiguo; Ji, Jiansong; Yang, Jie; Huang, Jiansheng; Zhao, Zhongwei; Gu, Ye; Bian, Li; Zhang, Zhen; Zou, Shengqiang; Ji, Hailei; Ge, Guohong; Du, Xiufang; Hou, Aifang; Zhu, Ying; Cong, Qingwei; Xu, Juan; Zu, Hongmei; Wang, Yun; Yan, Zhaolan; Yan, Xiaosong; Yangzhen, Bian Ba; Qu, Ci; Zhang, Liting; Yang, Shiying; Gao, Xiaoqin; Zhong, Li; He, Song; Liu, Chuan; Huang, Yifei; Liu, Yanna; Xu, Dan; Zhu, Qingliang; Xu, Xinxin; Lv, Muhan; Zhang, Wenhong; Qi, Xiaolong |
